Literature DB >> 25267423

Top 10 cardiovascular therapies and interventions for the next decade.

Valentin Fuster1.   

Abstract

Cardiovascular disease (CVD) has become the most-common cause of death worldwide. The Western lifestyle does not promote healthy living, and the consequences are most devastating when social inequalities are combined with economic factors and population growth. The expansion of poor nutritional habits, obesity, and associated conditions (such as diabetes mellitus, hypertension, physical inactivity, and advancing age) are major risk factors for developing CVD and are increasing in prevalence. Individuals in low-income and middle-income countries are undergoing a major shift in cardiovascular risk factors as they adopt Western lifestyles, a phenomenon that is hastened by industrialization, urbanization, and globalization. In this Perspectives article, I predict the 10 most-promising advances in cardiovascular therapies and interventions. Our improved understanding of CVD might help us, during the next decade, to achieve a transition from treating complex disease to promoting global cardiovascular health.

Entities:  

Mesh:

Year:  2014        PMID: 25267423     DOI: 10.1038/nrcardio.2014.137

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  133 in total

1.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

2.  Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia.

Authors:  Lionel H Opie
Journal:  Circulation       Date:  2008-04-29       Impact factor: 29.690

3.  Expert consensus document from the European Society of Cardiology on catheter-based renal denervation.

Authors:  Felix Mahfoud; Thomas Felix Lüscher; Bert Andersson; Iris Baumgartner; Renata Cifkova; Carlo Dimario; Pieter Doevendans; Robert Fagard; Jean Fajadet; Michel Komajda; Thierry Lefèvre; Chaim Lotan; Horst Sievert; Massimo Volpe; Petr Widimsky; William Wijns; Bryan Williams; Stephan Windecker; Adam Witkowski; Thomas Zeller; Michael Böhm
Journal:  Eur Heart J       Date:  2013-04-25       Impact factor: 29.983

4.  Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view.

Authors:  Jackson T Wright; Lawrence J Fine; Daniel T Lackland; Gbenga Ogedegbe; Cheryl R Dennison Himmelfarb
Journal:  Ann Intern Med       Date:  2014-04-01       Impact factor: 25.391

5.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2014-01-21       Impact factor: 29.690

6.  Plasma phospholipids identify antecedent memory impairment in older adults.

Authors:  Mark Mapstone; Amrita K Cheema; Massimo S Fiandaca; Xiaogang Zhong; Timothy R Mhyre; Linda H MacArthur; William J Hall; Susan G Fisher; Derick R Peterson; James M Haley; Michael D Nazar; Steven A Rich; Dan J Berlau; Carrie B Peltz; Ming T Tan; Claudia H Kawas; Howard J Federoff
Journal:  Nat Med       Date:  2014-03-09       Impact factor: 53.440

7.  Long-term mortality and morbidity results of the Veterans Administration randomized trial of coronary artery bypass surgery.

Authors:  K M Detre; T Takaro; H Hultgren; P Peduzzi
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

8.  Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese.

Authors:  Steven A Lubitz; Kathryn L Lunetta; Honghuang Lin; Dan E Arking; Stella Trompet; Guo Li; Bouwe P Krijthe; Daniel I Chasman; John Barnard; Marcus E Kleber; Marcus Dörr; Kouichi Ozaki; Albert V Smith; Martina Müller-Nurasyid; Stefan Walter; Joanne M Murabito; Moritz F Sinner; Vilmundur Gudnason; Stephan B Felix; Winfried März; Mina Chung; Christine M Albert; Bruno H Stricker; Toshihiro Tanaka; Susan R Heckbert; J Wouter Jukema; Alvaro Alonso; Emelia J Benjamin; Patrick T Ellinor; Sunil K Agarwal; Joshua C Bis; Jennifer A Brody; Lin Y Chen; Brendan M Everett; Ian Ford; Oscar H Franco; Tamara B Harris; Albert Hofman; Stefan Kääb; Saagar Mahida; Sekar Kathiresan; Michiaki Kubo; Lenore J Launer; Peter W MacFarlane; Jared W Magnani; Barbara McKnight; David D McManus; Annette Peters; Bruce M Psaty; Lynda M Rose; Jerome I Rotter; Guenther Silbernagel; Jonathan D Smith; Nona Sotoodehnia; David J Stott; Kent D Taylor; Andreas Tomaschitz; Tatsuhiko Tsunoda; Andre G Uitterlinden; David R Van Wagoner; Uwe Völker; Henry Völzke
Journal:  J Am Coll Cardiol       Date:  2014-01-30       Impact factor: 24.094

9.  LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study.

Authors:  Cesare Russo; Zhezhen Jin; Rui Liu; Shinichi Iwata; Aylin Tugcu; Mitsuhiro Yoshita; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Charles Decarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  JACC Cardiovasc Imaging       Date:  2013-03

10.  Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006.

Authors:  Harlan M Krumholz; Yun Wang; Jersey Chen; Elizabeth E Drye; John A Spertus; Joseph S Ross; Jeptha P Curtis; Brahmajee K Nallamothu; Judith H Lichtman; Edward P Havranek; Frederick A Masoudi; Martha J Radford; Lein F Han; Michael T Rapp; Barry M Straube; Sharon-Lise T Normand
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

View more
  12 in total

1.  Can the DNA damage response be harnessed to modulate atherosclerotic plaque phenotype?

Authors:  Babak Razani; Elaine W Raines
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

Review 2.  Cardiovascular Organ-on-a-Chip Platforms for Drug Discovery and Development.

Authors:  João Ribas; Hossein Sadeghi; Amir Manbachi; Jeroen Leijten; Katelyn Brinegar; Yu Shrike Zhang; Lino Ferreira; Ali Khademhosseini
Journal:  Appl In Vitro Toxicol       Date:  2016-06-01

3.  Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.

Authors:  Xavier Rossello; Antonio Piñero; Rodrigo Fernández-Jiménez; Javier Sánchez-González; Gonzalo Pizarro; Carlos Galán-Arriola; Manuel Lobo-Gonzalez; Jean Paul Vilchez; Jaime García-Prieto; Jose Manuel García-Ruiz; Ana García-Álvarez; David Sanz-Rosa; Borja Ibanez
Journal:  J Cardiovasc Transl Res       Date:  2018-08-02       Impact factor: 4.132

4.  Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute.

Authors:  Xavier Rossello; Zhenhe He; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2018-04       Impact factor: 3.727

Review 5.  The RISK pathway and beyond.

Authors:  Xavier Rossello; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2017-11-15       Impact factor: 17.165

Review 6.  Na/K-ATPase Signaling and Cardiac Pre/Postconditioning with Cardiotonic Steroids.

Authors:  Pauline V Marck; Sandrine V Pierre
Journal:  Int J Mol Sci       Date:  2018-08-09       Impact factor: 5.923

7.  Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKIIδ oxidation.

Authors:  Yuejin Wu; Qinchuan Wang; Ning Feng; Jonathan M Granger; Mark E Anderson
Journal:  Sci Rep       Date:  2019-06-26       Impact factor: 4.379

8.  Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction.

Authors:  Min Su Lee; Hyun Soo Park; Byung Chul Lee; Jae Ho Jung; Jung Sun Yoo; Sang Eun Kim
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

9.  p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice.

Authors:  Hai-Long Dai; Wei-Yuan Hu; Li-Hong Jiang; Le Li; Xue-Feng Gaung; Zhi-Cheng Xiao
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

10.  CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions.

Authors:  Xavier Rossello; Antonio Rodriguez-Sinovas; Gemma Vilahur; Verónica Crisóstomo; Inmaculada Jorge; Carlos Zaragoza; José L Zamorano; Javier Bermejo; Antonio Ordoñez; Lisardo Boscá; Jesús Vázquez; Lina Badimón; Francisco M Sánchez-Margallo; Francisco Fernández-Avilés; David Garcia-Dorado; Borja Ibanez
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.